CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Jiangsu Nhwa Pharmaceutical Company Limited Company Snapshot
Jiangsu Nhwa Pharmaceutical Company Limited operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Nhwa Pharmaceutical Company Limited with three other companies in this sector in China: Tibet Rhodiola Pharmaceutical Holding Company (2016 sales of 796.77 million Chinese Renmimbi [US$115.32 million] of which 100% was Pharmaceutical Manufacturing Industry), China Pioneer Pharma Holdings Ltd (1.79 billion Chinese Renmimbi [US$259.12 million] ), and China NT Pharma Group Co Ltd (915.12 million Chinese Renmimbi [US$132.45 million] ).

Sales Analysis. During the year ended December of 2016, sales at Jiangsu Nhwa Pharmaceutical Company Limited were 3.02 billion Chinese Renmimbi (US$436.72 million). This is an increase of 9.1% versus 2015, when the company's sales were 2.77 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Jiangsu Nhwa Pharmaceutical Company Limited (and since 2011, sales have increased a total of 90%). Sales of Medical Industrial Manufacturing saw an increase of 15.7% in 2016, from 1.42 billion Chinese Renmimbi to 1.65 billion Chinese Renmimbi. Not all segments of Jiangsu Nhwa Pharmaceutical Company Limited experienced an increase in sales in 2016: sales of Other Operation fell 97.4% to 1.00 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Jiangsu Nhwa Pharmaceutical Company Limited
  Stock Performance Chart for Jiangsu Nhwa Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 22.49
(Figures in Chinese Renmimbi)
1 Week 0.4%   13 Weeks 3.1%  
4 Weeks 7.2%   52 Weeks 40.8%  
 
Jiangsu Nhwa Pharmaceutical Company Limited Key Data:
  Ticker: 002262 Country: China
  Exchanges: SZN Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2016 Sales 3,017,258,480
(Year Ending Jan 2017).
Employees: 3,360
  Currency: Chinese Renmimbi Market Cap: 14,184,822,676
  Fiscal Yr Ends: December Shares Outstanding: 630,716,882
  Share Type: A Gu Closely Held Shares: 362,300,637
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.